Suspected Falsified Antimalarial Drug On Ghanaian Market – FDA

FDA Raise Alarm On Suspected Falsified Antimalarial Drug On Ghanaian Market


Sunyani February 22, 2023

The Food and Drugs Authority (FDA) says it has suspected falsified antimalarial drug on the Ghanaian market.

“The FDA as part of its market 

surveillance activities wishes to bring to the attention of health 

workers and the public, the presence of falsified (counterfeit) 

antimalarial drug- COMBIART Tablets (Artemether/Lumefantrine 20/120) on our market.

It said samples of this drug from the Northern Region did not contain any of the two active pharmaceutical ingredients stated on the label, hence can be classified as falsified.

The FDA therefore wishes to inform health workers and the general public to be on the lookout and report to the Authority the presence of this particular antimalarial drug- Combiart Tablets with the 

aforementioned details. 

Writer’s email: 

Leave a Reply

Your email address will not be published. Required fields are marked *